Inflammation at a previous inoculation site: An unusual presentation of Kawasaki disease

CMAJ. Canadian Medical Association Journal

Volumn 174, Issue 4, 2006, Pages 459-460

  Weinstein, Michael ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BCG VACCINE; HEMOGLOBIN; IMMUNOGLOBULIN; MYCOBACTERIUM ANTIGEN; TUBERCULIN;

ARTICLE; CASE REPORT; CHILD; FEMALE; HUMAN; INFLAMMATION; INOCULATION; MILIARY TUBERCULOSIS; MUCOCUTANEOUS LYMPH NODE SYNDROME; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; SKIN TEST; TUBERCULIN TEST; TUBERCULOUS MENINGITIS;

EID: 33644515636     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.051211     Document Type: Article

References (3)

1. Han RK, Sinclair B, Newman A, et al. Recognition and management of Kawasaki disease. CMAJ 2000;102(6):807-12.
2. Hsu YH, Wang YH, Hsu WY, et al. Kawasaki disease characterized by erythema and induration at the Bacillus Calmette-Guerin and purified protein derivative inoculation sites. Pediatr Infect Dis J 1987;6(6):576-7.
3. Sireci G, Dieli F, Salerno A. T cells recognize an immunodominant epitope of heat shock protein 65 in Kawasaki disease. Mol Med 2000;6(7):581-90.